Socure vs BioCatch

By valuation, Socure is the larger company at $4.5B versus $1.3B — a 3.5x difference. Size can also be measured by team: Socure employs 500-1000 people while BioCatch has 100-500 employees.

Socure has raised more in total funding at $750M, compared to BioCatch's $213M — a gap of $537M. Combined, the two companies have completed 4 known funding rounds.

Socure leads with an Awaira Score of 95/100, while BioCatch sits at 80/100. That 15-point gap reflects real differences in funding, scale, and traction — it's not a vanity metric.

Socure was founded by Johnny Ayers in 2012. BioCatch was founded by Avi Turgeman in 2011. Visit each company's profile on Awaira for a full founder biography.

Socure: Socure builds an AI-powered digital identity verification and fraud prevention platform used by financial institutions, fintechs, and government agencies to verify the identity of new customers and flag fraudulent account openings in real time. The platform aggregates data from thousands of digital signals, device intelligence, behavioral biometrics, and document verification to produce identity risk scores and predictive fraud models.\n\nThe company raised approximately 750 million USD, carries a valuation of approximately 4.5 billion USD, and serves over 2,700 customers including four of the five largest US banks, 13 of the top 15 card issuers, and hundreds of fintechs. Socure has built one of the largest real-identity networks in the financial sector, with identity verification coverage across over 70 percent of the US adult population.\n\nDigital identity fraud is escalating as synthetic identity fraud, account takeover, and deepfake-assisted impersonation become more sophisticated. Socure data network effect creates a compounding advantage: more customers feed more fraud signals back into the model, improving accuracy for all participants. The company holds a dominant market position in financial services identity verification and is expanding into government identity programs and healthcare, addressing a total available market measured in the tens of billions. Socure operates in the AI Security sector and is headquartered in United States. Founded in 2012 by Johnny Ayers, Socure has raised $750M in total funding, achieving a valuation of $4.5B as of its latest round. The company's funding journey includes a Series C of $35M in 2020, a Series D of $100M in 2021, a Series E of $450M in 2021. The most recent round was led by Accel. With approximately 500-1000 employees, Socure has established itself as a Series E-stage player in the AI Security market. The company holds an Awaira Score of 95/100, reflecting its strong position across valuation, funding trajectory, team scale, and market influence. Socure competes in a rapidly evolving segment alongside other AI Security companies. Based in United States, Socure is part of a growing international AI ecosystem attracting talent and investment. The AI Security space has attracted significant investment in recent years, with companies racing to capture enterprise and consumer demand for AI-powered solutions. BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection.

BioCatch got there first, launching in 2011 — that's 1 year of extra runway. Socure didn't arrive until 2012. In AI, that kind of head start means more training data, deeper customer relationships, and a bigger talent moat.

Socure has about 500-1000 employees; BioCatch has about 100-500. A bigger team usually means more revenue or heavier VC backing, but in AI, small teams can build at massive scale.

Yes — they're direct rivals. Both Socure and BioCatch compete in AI Security, targeting many of the same buyers. If you're evaluating one, you should be looking at the other.